G1D - Glucose transporter type 1 deficiency syndrome1. G1D 101- An Introduction
2. Treatment of G1D
3. Common questions after the diagnosis of G1D
4. G1D Research
5. Movement disorders in G1D
a. What are movement disorders? Movement disorders are a group of symptoms that indicate an impaired ability to produce and control body movement. Every body movement, from raising a hand to smiling, involves a complex interaction between the brain and spinal cord, nerves, and muscles. Damage to or malfunction of any of these components may result in a movement disorder. There is reason to believe that G1D movement disorders originate in the brain. The term 'paroxysmal' is also often used, to indicate the abnormal movements are sudden and unpredictable, with a fairly rapid return to normal. b. What movement disorders are seen in G1D?
c. Can GDT cause movement disorders and also seizures? Yes. Movement disorders may occur in G1D in isolation, in combination with other movement disorders, or in G1D patients who also have seizures and epilepsy. d. How are G1D movement disorders treated? The treatment of movement disorders in general may include several drugs prescribed by a neurologist. There is very limited experience with the use of these drugs in G1D, but there is no known reason to withhold any of these drugs in G1D, particularly if they show efficacy. However, the ketogenic diet has proven effective for the treatment of G1D-related movement disorders.
DISCLAIMER
All the information contained herein was made possible by the collaboration between The Child Brain Foundation, Dr. Juan M. Pascual, and The National Institute of Health's Office of Rare Diseases Research (Collaboration, Education and Test Translation Program). You may not commercially exploit any of the contents. Any redistribution or reproduction of part or all of the contents in any form is allowed and encouraged and proper acknowledgement is urged. To properly acknowledge the information contained here, please add the following to any excerpt or copy: "We acknowledge The Child Brain Foundation, www.childbrainfoundation.org, as the organizer, Dr. Juan Pascual as the author, and The National Institute of Health's Office of Rare Diseases Research (Collaboration, Education and Test Translation program, CETT Program) as the sponsor of this information." |